Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancers

12 May 2023

Abstract excerpt

BACKGROUND: Centrosomal protein 55 (CEP55) plays a significant role in specific cancers. However, comprehensive research on CEP55 is lacking in pan-cancer. METHODS: In-house and multi-center samples (n = 15,823) were used to analyze CEP55 in 33 cancers. The variance of CEP55 expression levels among tumor and control groups was evaluated by the Wilcoxon rank-sum test and standardized mean difference (SMD). The...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Ferroptosis and cancer prognosis
Share to Heat shock proteins research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37173675
DOI: 10.1186/s12890-023-02452-1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CEP55: an immune-related predictive and prognostic molecular biomarker for multiple cancersPMID 37173675Read ↗

Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancerSemantic proximity Read ↗

CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental VerificationSemantic proximity Read ↗

Upregulation of CEP55 Predicts Dismal Prognosis in Patients with Liver CancerSemantic proximity Read ↗

Centrosomal Protein 55 (CEP55) Drives Immune Exclusion and Resistance to Immune Checkpoint Inhibitors in Colorectal CancerSemantic proximity Read ↗

Pan-cancer analysis of oncogenic role of CEP55 and experiment validation in clear cell renal cell carcinomaSemantic proximity Read ↗

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSCSemantic proximity Read ↗

Genetic Ablation and Multi-Omics Profiling Reveal CEP55 as a Key Driver of Tumorigenesis in Diverse Cancer ModelsSemantic proximity Read ↗

CEP55 promotes cell proliferation and inhibits apoptosis via the PI3K/Akt/p21 signaling pathway in human glioma U251 cellsSemantic proximity Read ↗

Genetic Ablation and Multi-Omics Profiling Reveal CEP55 as a Key Driver of Tumorigenesis in Diverse Cancer ModelsSemantic proximity Read ↗

Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses.Semantic proximity Read ↗

CEP55 3’-UTR promotes epithelial–mesenchymal transition and enhances tumorigenicity of bladder cancer cells by acting as a ceRNA regulating miR- 497-5pSemantic proximity Read ↗

ZNF165: A Pan-Cancer Biomarker with Prognostic and Therapeutic PotentialSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.